{"id":"W4315473447","doi":"10.1182/blood.2022017734","title":"Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Rituximab; Hazard ratio; Prednisone; Vincristine; Population; CHOP; Gastroenterology; Adverse effect; Confidence interval; Cyclophosphamide; Surgery; Oncology; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003845537,0.0006226096,0.001051226,0.0002040657,0.0001656048,0.0007799987,0.0003960495,0.0002980164,0.000932186],"category_scores_gemma":[0.001386865,0.0001904783,0.001330941,0.0004590511,0.0003340378,0.0004926292,0.0005016104,0.001270287,0.0001984342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004858352,"about_ca_system_score_gemma":0.0007954551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005345044,"about_ca_topic_score_gemma":0.001489332,"domain_scores_codex":[0.999225,0.0005146285,0.00003855689,0.00008343694,0.00006348801,0.00007488103],"domain_scores_gemma":[0.9989265,0.0002792267,0.0002839246,0.0002066533,0.0000941761,0.0002095071],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6661085,0.002717171,0.1441968,0.001113573,0.009856375,0.0004329684,0.0006111921,0.005411582,0.01039411,0.0006881888,0.005283637,0.1531859],"study_design_scores_gemma":[0.43581,0.1346501,0.3712681,0.0003468017,0.01719777,0.001805664,0.0005975275,0.01253388,0.005620079,0.00262255,0.01742636,0.0001211455],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953299,0.002290448,0.0003006917,0.0001767493,0.00002269752,0.0001584159,0.0005261138,0.00002158326,0.001173565],"genre_scores_gemma":[0.9950399,0.00115064,0.0004709125,0.0004133561,0.00005666846,0.0002329861,0.002168015,0.00001662073,0.0004509524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003845537,"threshold_uncertainty_score":0.0203374,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03081661418020136,"score_gpt":0.3290154114159041,"score_spread":0.2981987972357028,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}